Pierre Amarenco
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management 40
-
- Antiplatelet Therapy and Cardiovascular Diseases 57
- Atrial Fibrillation Management and Outcomes 37
- Neurology top 0.1%
- Intracranial Aneurysms: Treatment and Complications 32
- Epidemiology top 0.05%
- Acute Ischemic Stroke Management 148
- Pulmonary and Respiratory Medicine top 0.05%
- Cerebrovascular and Carotid Artery Diseases 134
- Aortic Thrombus and Embolism 22
-
- Lipoproteins and Cardiovascular Health 67
- Co-authors
- Julien LabreuchePierre‐Jean TouboulPhilippa C. LavalléeMichael G. HennericiMarie‐Germaine BousserMikaël MazighiGregory W. AlbersGeoffrey A. Donnan
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Pierre Amarenco
352 papers receiving 24.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Internal Medicine 2.2k
- Cardiology and Cardiovascular Medicine 8.7k
- Neurology 5.1k
- Epidemiology 10.6k
- Pulmonary and Respiratory Medicine 9.9k
Countries citing papers authored by Pierre Amarenco
This map shows the geographic impact of Pierre Amarenco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Amarenco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Amarenco more than expected).
Fields of papers citing papers by Pierre Amarenco
This network shows the impact of papers produced by Pierre Amarenco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Amarenco. The network helps show where Pierre Amarenco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Amarenco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 14 | |
| 6 | 2021 | 11 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 21 | |
| 9 | 2019 | 6 | |
| 10 | 2017 | 15 | |
| 11 | 2017 | 3 | |
| 12 | 2016 | 18 | |
| 13 | 2013 | 32 | |
| 14 | 2013 | 174 | |
| 15 | 2010 | 36 | |
| 16 | 2009 | 177 | |
| 17 | 2009 | 22 | |
| 18 | 2008 | 173 | |
| 19 | Higher Aspirin Dose is Associated with Reduced Mortality and More Serious Bleeding in Patients with Recent Cerebrovascular or Coronary Ischemic Events: Insights from the BRAVO Trial | 2003 | 1 |
| 20 | Athérosclérose aortique : marqueur du risque vasculaire | 1997 | 1 |
About Pierre Amarenco
Pierre Amarenco is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Neurology, having authored 362 papers that have together received 25.1k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (148 papers), Cerebrovascular and Carotid Artery Diseases (134 papers), Lipoproteins and Cardiovascular Health (67 papers), Antiplatelet Therapy and Cardiovascular Diseases (57 papers), Venous Thromboembolism Diagnosis and Management (40 papers), Atrial Fibrillation Management and Outcomes (37 papers), Intracranial Aneurysms: Treatment and Complications (32 papers) and Aortic Thrombus and Embolism (22 papers). The work is most often cited by research in Internal Medicine (2.2k citations), Cardiology and Cardiovascular Medicine (8.7k citations) and Neurology (5.1k citations). Pierre Amarenco has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Julien Labreuche, Pierre‐Jean Touboul, Philippa C. Lavallée, Michael G. Hennerici, Marie‐Germaine Bousser, Mikaël Mazighi, Gregory W. Albers, Geoffrey A. Donnan, Isabelle Klein and Elena Meseguer. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.